J&J | JNJ - Operating Profit



J&J reported $6.94B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Abbott USD 2.07B 415M Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Baxter International USD 272M 214M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Boston Scientific USD 942M 21M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
CONMED USD 38.16M 22.2M Jun/2025
Cooper Companies USD 175.7M 9.1M Jul/2025
Dexcom USD 212.6M 78.9M Jun/2025
Edwards Lifesciences USD 430.9M 36.1M Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
Globus Medical USD -125953000 222.96M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Insulet USD 121.1M 71.8M Jun/2025
Integra LifeSciences USD -1309000 14.65M Jun/2025
Intuitive Surgical USD 746.9M 168.8M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Medtronic USD 1.52B 81M Jul/2025
Merck USD 6.36B 494M Jun/2025
Merit Medical Systems USD 47.02M 5.99M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Regeneron Pharmaceuticals USD 1.08B 487.8M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
Stryker USD 1.17B 331M Jun/2025
Tandem Diabetes Care USD -31859000 89.02M Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025
Vertex Pharmaceuticals USD 1.15B 123.1M Jun/2025
Zimmer Biomet Holdings USD 396.4M 57.5M Jun/2025
Zoetis USD 1.02B 205M Jun/2025